GGrantIndex
← Leaderboards

H. Lee Moffitt Cancer Ctr &Res Inst

Tampa, FL

Compare ↔
$54,657,876
Total funding
92
Grants

Funding mix

By agency

NIH$59,007,276 · 93
CDC$0 · 1

By mechanism

R01$32,810,766 · 48
U01$10,641,133 · 4
R21$4,353,356 · 12
P30$2,349,400 · 1
U54$2,000,000 · 1
P20$1,686,563 · 1

Investigators at H. Lee Moffitt Cancer Ctr &Res Inst

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

1Pamela N Munster$9,080,8217 gr2Tuya Pal$5,814,4943 gr3Rebecca Sutphen$5,809,5922 gr4Pearlie K Epling-Burnette$2,267,4882 gr5Johnathan Mark Lancaster$1,568,5404 gr6Thaddeus A Herzog$1,521,0203 gr7Sheng Wei$1,384,8461 gr8Wei Qian$1,167,9012 gr

Largest grants

Data Coordinating Center$5,000,000
U01 · FY2002 · DK
MOFFITT CANCER CENTER SUPPORT GRANT$2,241,839
P30 · FY2005 · CA
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION$2,000,000
C06 · FY2002 · RR
Rare Diseases Data and Technology Coordinating Center$2,000,000
U54 · FY2003 · RR
Natural History of HPV Infection in Men: The HIM Study$1,655,450
R01 · FY2005 · CA
Data Coordinating Center$1,568,300
U01 · FY2003 · DK
Inhibitors of Rho function as novel cancer therapeutics$1,127,634
U19 · FY2005 · CA
Natural History of HPV Infection in Men: The HIM Study$1,018,231
R01 · FY2004 · CA
Exisulind for Chemoprevention of Lung Cancer$1,017,332
U01 · FY2005 · CA
Exisulind for Chemoprevention of Lung Cancer$998,823
U01 · FY2004 · CA
Exisulind for Chemoprevention of Lung Cancer$976,569
U01 · FY2003 · CA
Moffitt Aging and Cancer Program Development$687,120
P20 · FY2005 · CA
Population-Based Analysis of Ovarian Cancer Biomarkers$637,944
R01 · FY2005 · CA
Screening for Breast Cancer Using Molecular Signatures$570,951
R01 · FY2003 · CA
Screening for Breast Cancer Using Molecular Signatures$566,092
R01 · FY2005 · CA
Patient Navigator Program$558,785
U01 · FY2005 · CA
Screening for Breast Cancer Using Molecular Signatures$549,601
R01 · FY2004 · CA
RRM1/PTEN Axis in Non-Small Cell Lung Cancer$545,108
R01 · FY2005 · CA
RRM1/PTEN Axis in Non-Small Cell Lung Cancer$531,731
R01 · FY2004 · CA
Ovarian Cancer and Mismatch Repair Deficiency$522,611
R01 · FY2005 · CA